Nature Research Round Table: Human Pluripotent Stem Cell Lines as Disease Models
Dr. Christine Mummery from the Leiden University Medical Center discusses the use of human pluripotent stem cells (hPSCs) for disease modeling and what standards are required; including for genome integrity, routine checks, and journal requirements.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Nature Research Round Table: The Process of Human Pluripotent Stem Cell Adaptation
Dr. Ivana Barbaric from the Center for Stem Cell Biology at the University of Sheffield talks about culture-acquired genetic changes in human pluripotent stem cells (hPSCs), ways of detecting them, and implications for research and downstream clinical therapies. This presentation and the following Q&A session were moderated by Dr. Peter Andrews from the University of Sheffield.
This presentation was part of a Round Table series titled "Challenges in Ensuring hPSC Quality", hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Nature Research Round Table: Parkinson's Disease Therapy with Human Embryonic Stem Cells
Dr. Malin Parmar from Lund University talks about her work on cell-based therapies to treat Parkinson’s disease, as well as regulatory, safety, and efficacy requirements for the clinic. This presentation and the following Q&A session were moderated by Dr. Christine Mummery from the Leiden University Medical Center.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
EasySep™小鼠TIL（CD45）正选试剂盒
Nature Research Round Table: Human Pluripotent Stem Cell Lines as Disease Models Dr. Christine Mummery from the Leiden University Medical Center discusses the use of human pluripotent stem cells (hPSCs) for disease modeling and what standards are required; including for genome integrity, routine checks, and journal requirements.
Nature Research Round Table: The Process of Human Pluripotent Stem Cell Adaptation Dr. Ivana Barbaric from the Center for Stem Cell Biology at the University of Sheffield talks about culture-acquired genetic changes in human pluripotent stem cells (hPSCs), ways of detecting them, and implications for research and downstream clinical therapies. This presentation and the following Q&A session were moderated by Dr. Peter Andrews from the University of Sheffield.
Mammalian Cell Cloning Procedure: Customizable Semi-Solid Cloning with ClonaCell™ FLEX Medium This video outlines the ClonaCell™ FLEX procedure for semi-solid cloning, including preparation of the cells, plating, colony picking, and expansion
Nature Research Round Table: Parkinson's Disease Therapy with Human Embryonic Stem Cells Dr. Malin Parmar from Lund University talks about her work on cell-based therapies to treat Parkinson’s disease, as well as regulatory, safety, and efficacy requirements for the clinic. This presentation and the following Q&A session were moderated by Dr. Christine Mummery from the Leiden University Medical Center.
